SCHEMBL21784644

SCHEMBL21784644

CC1(C)OB(c2cccc3oc4cc5oc6ccccc6c5cc4c23)OC1(C)C

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAOA P21397 2/20 0.43
AHR P35869 2/20 0.41
PGR P06401 1/20 0.39
CYP1A2 P05177 2/20 0.38
MEN1 O00255 6/20 0.37
KMT2A Q03164 6/20 0.37
MAPT P10636 3/20 0.37
KDM4E B2RXH2 3/20 0.37
ALDH1A1 P00352 3/20 0.37
HPGD P15428 3/20 0.37
NPC1 O15118 3/20 0.37
RAB9A P51151 2/20 0.37
SMN1; SMN2 Q16637 2/20 0.37
CYP2C19 P33261 2/20 0.33
LPL P06858 2/20 0.33
LIPG Q9Y5X9 2/20 0.33
TSHR P16473 1/20 0.33
ACHE P22303 1/20 0.33
GAA P10253 2/20 0.32
HSD17B10 Q99714 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30154380 0.88 CDC14B (0.39) MAOAAHRPGRMEN1KMT2A
SCHEMBL17242061 0.88 CDC14B (0.39) MAOAAHRPGRMEN1KMT2A
SCHEMBL21204181 0.88 MAOA (0.43) MAOAAHRPGRCYP1A2MEN1
SCHEMBL22658234 0.86 MAOA (0.42) MAOAAHRPGRCYP1A2MEN1
SCHEMBL22147260 0.85 MAOA (0.40) MAOAAHRPGRCYP1A2MEN1
SCHEMBL19917048 0.84 LPL (0.41) MAOANPC1RAB9ALPLLIPG
SCHEMBL21204178 0.83 MEN1 (0.41) MAOAAHRPGRCYP1A2MEN1
SCHEMBL19802899 0.83 LIPG (0.38) MAOAAHRMEN1KMT2AMAPT
SCHEMBL22073929 0.82 LIPG (0.44) AHRPGRMEN1KMT2AMAPT
SCHEMBL20815923 0.82 AHR (0.40) MAOAAHRPGRCYP1A2MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220109115-A1 POLYCYCLIC COMPOUND, AND AN ORGANIC ELECTROLUMINESCENCE DEVICE COMPRISING THE POLYCYCLIC COMPOUND IDEMITSU KOSAN CO.,LTD. (JP) 2022-04-07 US disclosed
WO-2020044270-A1 POLYCYCLIC COMPOUND, AND AN ORGANIC ELECTROLUMINESCENCE DEVICE COMPRISING THE POLYCYCLIC COMPOUND IDEMITSU KOSAN CO., LTD. (JP) 2020-03-05 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220109115-A1 POLYCYCLIC COMPOUND, AND AN ORGANIC ELECTROLUMINESCENCE DEVICE COMPRISING THE POLYCYCLIC COMPOUND ODC1, OTC, PKD1 MAOA 355/4885AHR 2150/4885PGR 756/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.